June 2025: Strategic Consolidation and Sector-Specific Momentum
June 2025 was a month of consolidation-driven activity and strategic repositioning in India’s private equity and venture capital landscape. The spotlight was firmly on the healthcare and pharma sector, which accounted for the lion’s share of deal value. The biggest headline came from Torrent Pharma’s $3 billion acquisition of JB Chemicals from KKR, one of the largest pharma transactions in India to date. Equally notable was Manipal Health’s $800 million bid for Sahyadri Hospitals, which drew interest from global PE giants like EQT and TPG.
India’s PE/VC Landscape in May 2025: A Month of Strategic Depth and Sectoral Diversity
May 2025 turned out to be a vibrant month for private equity and venture capital activity in India, with over $1.15 billion deployed across 18+ deals. Investment momentum spanned across sectors—from healthcare and logistics to entertainment and consumer brands—underscoring the resilience and breadth of India’s growth story. A major highlight was PB Healthcare Services’ $218 million raise, signaling a strong shift into healthcare infrastructure by digital insurance giant PB Fintech. Porter’s $200 million fundraise, which pushed it into the unicorn club, highlighted continued investor confidence in tech-led logistics platforms. Consumer-focused startups like Lahori and The Good Bug also attracted significant capital, reflecting the enduring appeal of homegrown health and wellness brands.
Pages: 1 2
